Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 918 results for "gsk"

MHRA, IATA, IAG Cargo, American Airlines, Sanofi Aventis and GSK to speak at Cold Chain Distribution- 2014
PRWeb

MHRA, IATA, IAG Cargo, American Airlines, Sanofi Aventis and G...

SMi's 9th annual Cold Chain Distribution will be taking place in Central London, on the 2nd and 3rd of December 2014. SMi's 9th annual Cold Chain Distribution Conference and Exhibition will be taking place in London, UK, on the 2nd and 3rd of ... PRWeb, 15 hours ago
[x]  

497 images for gsk

Talking Retail, 19 hours ago
QCK.com, 13 hours ago
InvestorPlace.com, 4 days ago
Pharmafocus, 4 days ago
Livemint.com, 4 days ago
voanews.com, 4 days ago
Spy Ghana, 6 days ago
Moneycontrol.com, 5 days ago
Charlotte Observer, 4 days ago
Philly.com, 4 days ago
Talking Retail

GSK appoints new sales director

GSK Consumer Healthcare has announced the appointment of Slawomir Szymankiewicz as sales director for its Great Britain and Ireland business. He was previously general manager for GSK Consumer Healthcare in Russia, having joined GSK in 1994. ...
 Talking Retail20 hours ago GSK warns on profits as weak lung drug sales hit  Business Standard1 month ago GlaxoSmithKline appoint new head of sales  Pharmacy.Biz4 days ago

India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden

MUMBAI, Sept 1 (Reuters) - India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product.Cipla's ...
 London South East16 hours ago Cipla launches copy of GSK's asthma drug in Germany, Sweden  Financial Express9 hours ago Cipla Ltd launches copy of GSK's top asthma drug in Germany, Sweden  Economic Times14 hours ago Cipla launches copy of GSK's top asthma drug in Germany, Sweden  Smart Investor15 hours ago
[x]  

GSK's chairman urged to resign earlier over China bribery scandal

Jessica Fino UK pharmaceutical group GlaxoSmithKline (GSK) is facing rebellion from its shareholders as they call for an early departure from chairman Christopher Gent, reports said. Gent has been GSK's chairman for nine years, and announced ...
 BullBearings14 hours ago
[x]  
International Business Times UK

GSK to start clinical trials on new Ebola vaccine

London-listed pharmaceuticals company GlaxoKlineSmith will start clinical safety trials for its experimental Ebola vaccine in the U.S. as early as next week, sources told news agencies Reuters and Bloomberg . The current Ebola outbreak in West ...
 Processing Magazine3 days ago Testing on Experimental Ebola Vaccine to Begin in U.S.  ADVFN India4 days ago GSK Leading Race For Ebola Vaccine  Bidness Etc4 days ago GSK Ebola vaccine fast-tracked into U.S., UK and African trials  Reuters Africa4 days ago
[x]  
FDA News

GSK Secures FDA Approval of Promacta

GlaxoSmithKline plc reported that the U.S. Food and Drug Administration has approved a supplemental New Drug Application for the once-daily use of Promacta in patients with severe aplastic anaemia who have had an insufficient response to ...
 Individual.com4 days ago FDA clears GSK's Promacta sNDA to treat SAA patients  Pharmaceutical Technology4 days ago Global Intranasal Drug Delivery Market 2014-2018 with Becton, Dickinson and Company, GSK, Johnson & Johnson, & Novartis Dominating  Individual.com5 days ago Ligand's Partner GSK Gets FDA Approval Of SNDA For Promacta/Revolade  RTTNews.com5 days ago
[x]  

GSK-CH relaunches Horlicks

Last week, GSK consumer healthcare re-launched it's flagship health drink Horlicks with a new logo, packaging and commercial. Pavni Mittal of Storyboard caught up with Jayant Singh to understand the changes made to the brand and how it would be marketed.
 Money Control2 days ago Prospects for the GSK and Novartis Consumer Health Joint Venture  Euromonitor International3 days ago GSK India relaunches Horlicks  Hindu Business Line6 days ago GlaxoSmithKline Consumer Healthcare : GSK INDIA RELAUNCHES HORLICKS  4 Traders4 days ago
[x]  

Why GlaxoSmithKline (GSK) Stock Is Gaining Today

NEW YORK (TheStreet) -- GlaxoSmithKline (GSK) Must Read: Warren Buffett's 25 Favorite Stocks TheStreet Ratings team rates GLAXOSMITHKLINE PLC as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation: ...
 TheStreet.com4 days ago Top 3 Yielding Buy-Rated Stocks: PAA, VZ, GSK  TheStreet.com5 days ago 3 Drugs Stocks On The Rise  TheStreet.com5 days ago

Tekmira Surges On Takeover Rumors

Tekmira continues to soar in extended trading after rumors surfaced that big pharmaceuticals like GSK and Shire are looking to acquire the Canada-based pharmaceutical Page 1 of 2 Click Ticker to See live coverage Tekmira ...
 Bidness Etc4 days ago Tekmira Pharmaceuticals (TKMR) Stock Up on Rumored Takeover  InvestorGuide.com4 days ago Tekmira +4% on takeover rumors; Shire, Glaxo said to have interest  Seeking Alpha5 days ago
Forbes.com

GSK & NIAID Ebola Vaccine To Enter UK Human Safety Trials; Broad International Collaboration

The Wellcome Trust, the Medical Research Council (MRC), and the UK Department for International Development (DFID) have announced this morning that an Ebola vaccine developed in the U.S. will enter human safety trials in the UK as early as ...
 Austin American Statesman4 days ago GSK/NIAID Ebola Vaccines To Enter US, UK Human Safety Trials  Forbes.com4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less